| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | MDH21334PI |
| InChI Key | ZBVPUFSKFGYNLC-FIDNPTQWSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C24H30N2O3S |
| Molecular Weight | 426.58 |
| AlogP | 2.8 |
| Hydrogen Bond Acceptor | 4.0 |
| Hydrogen Bond Donor | 2.0 |
| Number of Rotational Bond | 6.0 |
| Polar Surface Area | 69.64 |
| Molecular species | BASE |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 30.0 |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Cytochrome P450
Cytochrome P450 family 2
Cytochrome P450 family 2D
Cytochrome P450 2D6
|
- | - | - | - | 6 | |
|
Ion channel
Voltage-gated ion channel
Potassium channels
Voltage-gated potassium channel
|
- | 1600 | - | - | - | |
|
Membrane receptor
Family A G protein-coupled receptor
Peptide receptor (family A GPCR)
Short peptide receptor (family A GPCR)
Opioid receptor
|
- | - | - | 0-1 | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Obesity | 2 | D009765 | ClinicalTrials |
| Alcoholism | 2 | D000437 | ClinicalTrials |
| Sexual Dysfunction, Physiological | 2 | D012735 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL3219616 |
| DrugBank | DB12196 |
| FDA SRS | MDH21334PI |
| PubChem | 11154544 |
| SureChEMBL | SCHEMBL14161503 |
| ZINC | ZINC000169323664 |